Aine E Clements, MD | Gynecological ...

Dr. Aine E. Clements

Claim this profile

OhioHealth Mansfield Hospital

Studies Ovarian Cancer
Studies Cancer
7 reported clinical trials
32 drugs studied

Area of expertise

1

Ovarian Cancer

Aine E. Clements has run 4 trials for Ovarian Cancer. Some of their research focus areas include:

KRAS positive
Stage IV
NRAS positive
2

Cancer

Aine E. Clements has run 3 trials for Cancer. Some of their research focus areas include:

Stage I
Stage IV
Stage II

Affiliated Hospitals

Image of trial facility.

OhioHealth Mansfield Hospital

Image of trial facility.

Riverside Methodist Hospital

Clinical Trials Aine E. Clements is currently running

Image of trial facility.

Chemotherapy

for Cancer

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.

Recruiting

2 awards

Phase 3

26 criteria

Image of trial facility.

Targeted Therapy

for Solid Tumors

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.

Recruiting

1 award

Phase 2

17 criteria

More about Aine E. Clements

Clinical Trial Related

3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Aine E. Clements has experience with

  • Selumetinib Sulfate
  • Ipatasertib
  • Binimetinib
  • Palbociclib
  • Olaparib
  • Levonorgestrel-Releasing Intrauterine System

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Aine E. Clements specialize in?

Is Aine E. Clements currently recruiting for clinical trials?

Are there any treatments that Aine E. Clements has studied deeply?

What is the best way to schedule an appointment with Aine E. Clements?

What is the office address of Aine E. Clements?

Is there any support for travel costs?